These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 25663916)
1. Quantitative detection of methylated NDRG4 gene as a candidate biomarker for diagnosis of colorectal cancer. Xiao W; Zhao H; Dong W; Li Q; Zhu J; Li G; Zhang S; Ye M Oncol Lett; 2015 Mar; 9(3):1383-1387. PubMed ID: 25663916 [TBL] [Abstract][Full Text] [Related]
2. A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma. Liu R; Su X; Long Y; Zhou D; Zhang X; Ye Z; Ma J; Tang T; Wang F; He C Mutat Res Rev Mutat Res; 2019; 779():45-57. PubMed ID: 31097151 [TBL] [Abstract][Full Text] [Related]
3. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783 [TBL] [Abstract][Full Text] [Related]
4. DNA methylation analysis of SFRP2, GATA4/5, NDRG4 and VIM for the detection of colorectal cancer in fecal DNA. Lu H; Huang S; Zhang X; Wang D; Zhang X; Yuan X; Zhang Q; Huang Z Oncol Lett; 2014 Oct; 8(4):1751-1756. PubMed ID: 25202404 [TBL] [Abstract][Full Text] [Related]
5. TFPI2 and NDRG4 gene promoter methylation analysis in peripheral blood mononuclear cells are novel epigenetic noninvasive biomarkers for colorectal cancer diagnosis. Bagheri H; Mosallaei M; Bagherpour B; Khosravi S; Salehi AR; Salehi R J Gene Med; 2020 Aug; 22(8):e3189. PubMed ID: 32196834 [TBL] [Abstract][Full Text] [Related]
6. Significance of SDC2 and NDRG4 methylation in stool for colorectal cancer diagnosis. Long L; Sun Q; Yang F; Zhou H; Wang Y; Xiao C; He Q; Yi B Clin Biochem; 2024 Feb; 124():110717. PubMed ID: 38224931 [TBL] [Abstract][Full Text] [Related]
7. DNA methylation biomarkers in stool for early screening of colorectal cancer. Chen J; Sun H; Tang W; Zhou L; Xie X; Qu Z; Chen M; Wang S; Yang T; Dai Y; Wang Y; Gao T; Zhou Q; Song Z; Liao M; Liu W J Cancer; 2019; 10(21):5264-5271. PubMed ID: 31602277 [No Abstract] [Full Text] [Related]
8. Is methylation analysis of Park SK; Baek HL; Yu J; Kim JY; Yang HJ; Jung YS; Choi KY; Kim H; Kim HO; Jeong KU; Chun HK; Kim K; Park DI Intest Res; 2017 Oct; 15(4):495-501. PubMed ID: 29142517 [TBL] [Abstract][Full Text] [Related]
9. Evaluating the clinical performance of Zhang K; He Q; Cao Q; Chuan J; Qin A; Tang L; Zhang X; Xiao C; Zhu B; Hu M; Chang L; Bu ZX; Fu L; Yang T; Wang Y; Liu W Epigenomics; 2024 Jan; 16(2):93-108. PubMed ID: 38226561 [TBL] [Abstract][Full Text] [Related]
10. Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer. Oh T; Kim N; Moon Y; Kim MS; Hoehn BD; Park CH; Kim TS; Kim NK; Chung HC; An S J Mol Diagn; 2013 Jul; 15(4):498-507. PubMed ID: 23747112 [TBL] [Abstract][Full Text] [Related]
11. The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis. Mojtabanezhad Shariatpanahi A; Yassi M; Nouraie M; Sahebkar A; Varshoee Tabrizi F; Kerachian MA PLoS One; 2018; 13(7):e0200735. PubMed ID: 30024936 [TBL] [Abstract][Full Text] [Related]
12. Stool DNA methylation assays in colorectal cancer screening. Kadiyska T; Nossikoff A World J Gastroenterol; 2015 Sep; 21(35):10057-61. PubMed ID: 26401070 [TBL] [Abstract][Full Text] [Related]
13. Quantification of methylated markers with a multiplex methylation-specific technology. Zou H; Allawi H; Cao X; Domanico M; Harrington J; Taylor WR; Yab T; Ahlquist DA; Lidgard G Clin Chem; 2012 Feb; 58(2):375-83. PubMed ID: 22194633 [TBL] [Abstract][Full Text] [Related]
14. Detection of SPG20 gene promoter-methylated DNA, as a novel epigenetic biomarker, in plasma for colorectal cancer diagnosis using the MethyLight method. Rezvani N; Alibakhshi R; Vaisi-Raygani A; Bashiri H; Saidijam M Oncol Lett; 2017 May; 13(5):3277-3284. PubMed ID: 28521434 [TBL] [Abstract][Full Text] [Related]
15. A novel method to capture methylated human DNA from stool: implications for colorectal cancer screening. Zou H; Harrington J; Rego RL; Ahlquist DA Clin Chem; 2007 Sep; 53(9):1646-51. PubMed ID: 17712002 [TBL] [Abstract][Full Text] [Related]
16. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia. Lidgard GP; Domanico MJ; Bruinsma JJ; Light J; Gagrat ZD; Oldham-Haltom RL; Fourrier KD; Allawi H; Yab TC; Taylor WR; Simonson JA; Devens M; Heigh RI; Ahlquist DA; Berger BM Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1313-8. PubMed ID: 23639600 [TBL] [Abstract][Full Text] [Related]
17. Identification and validation of colorectal neoplasia-specific methylation biomarkers based on CTCF-binding sites. Liu J; Ding Z; Li G; Tang L; Xu Y; Luo H; Yi J; Lu Y; Mao R; Nan Q; Ren L; Zhang T; Wang K Oncotarget; 2017 Dec; 8(69):114183-114194. PubMed ID: 29371978 [TBL] [Abstract][Full Text] [Related]
18. Stool methylated DNA markers decrease following colorectal cancer resection--implications for surveillance. Kisiel JB; Yab TC; Taylor WR; Mahoney DW; Ahlquist DA Dig Dis Sci; 2014 Aug; 59(8):1764-7. PubMed ID: 24993691 [TBL] [Abstract][Full Text] [Related]
19. A novel plasma based early colorectal cancer screening assay base on methylated SDC2 and SFRP2. Zhao G; Ma Y; Li H; Li S; Zhu Y; Liu X; Xiong S; Liu Y; Miao J; Fei S; Zheng M; Zhao X Clin Chim Acta; 2020 Apr; 503():84-89. PubMed ID: 31962098 [TBL] [Abstract][Full Text] [Related]
20. DNA methylation of CMTM3, SSTR2, and MDFI genes in colorectal cancer. Li J; Chen C; Bi X; Zhou C; Huang T; Ni C; Yang P; Chen S; Ye M; Duan S Gene; 2017 Sep; 630():1-7. PubMed ID: 28782576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]